相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues
Edgar J. Rolleman et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Highly Efficient In Vivo Agonist-Induced Internalization of sst(2) Receptors in Somatostatin Target Tissues
Bea Waser et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Hyperkalaemia
Moffat J. Nyirenda et al.
BRITISH MEDICAL JOURNAL (2009)
Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE:: the role of associated risk factors
Lisa Bodei et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Reducing renal uptake of radiolabeled peptides using albumin fragments
Erik Vegt et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Gastroenteropancreatic neuroendocrine tumours
Irvin M. Modlin et al.
LANCET ONCOLOGY (2008)
Comparison of [177Lu-DOTA0, Tyr3] octreotate and [177Lu- DOTA0, Tyr3] octreotide:: which peptide is preferable for PRRT?
J. P. Esser et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)
Difficulties in maintaining potassium homeostasis in patients with heart failure
Ihsan Dursun et al.
CLINICAL CARDIOLOGY (2006)
Metabolic effects of amino acid solutions infused for renal protection during therapy with radiolabelled somatostatin analogues
R Barone et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
A comparison of 111In-DOTATOC and 111In-DOTATATE:: biodistribution and dosimetry in the same patients with metastatic neuroendocrine tumours
F Forrer et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2004)
Receptor radionuclide therapy with 90Y-[DOTA]0-Tyr3-octreotide (90Y-DOTATOC) in neuroendocrine tumours
L Bodei et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2004)
86Y-DOTA0-D-Phe1-Tyr3-octreotide (SMT487) -: a phase 1 clinical study:: pharmacokinetics, biodistribution and renal protective effect of different regimens of amino acid co-infusion
F Jamar et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)
Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion:: a phase I study
L Bodei et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)
Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginine
EJ Rolleman et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)
Hyperkalemia in congestive heart failure patients aged 63 to 85 years with subclinical renal disease
CI Obialo et al.
AMERICAN JOURNAL OF CARDIOLOGY (2002)
分享论文
